Silence Therapeutics plc (NASDAQ:SLN – Get Free Report)’s stock price gapped up before the market opened on Friday . The stock had previously closed at $23.07, but opened at $23.84. Silence Therapeutics shares last traded at $23.97, with a volume of 99,196 shares changing hands. Wall Street Analyst Weigh In Several brokerages recently issued reports […]
Silence Therapeutics plc: Silence Therapeutics Achieves $10 Million Milestone Payment from AstraZeneca Collaboration Following the Initiation of Phase 1 Trial finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Silence Therapeutics plc, (NASDAQ: SLN) shares moved higher Friday, as the experienced and innovative biotechnology company announced that the initiation by AstraZeneca of a phase 1 clinical trial of the first product candidate under its siRNA (short .
Shares of Silence Therapeutics plc (OTCMKTS:SLNCF – Get Free Report) shot up 30% during trading on Wednesday . The stock traded as high as $3.25 and last traded at $3.25. 500 shares were traded during trading, a decline of 6% from the average session volume of 533 shares. The stock had previously closed at $2.50. […]
Silence Therapeutics plc (NASDAQ:SLN – Get Free Report) shares gapped up prior to trading on Friday . The stock had previously closed at $23.07, but opened at $23.84. Silence Therapeutics shares last traded at $23.97, with a volume of 99,196 shares. Analysts Set New Price Targets SLN has been the subject of a number of […]